4LL Stock Overview Provides virtual healthcare services worldwide. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Teladoc Health, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Teladoc Health Historical stock prices Current Share Price US$9.02 52 Week High US$20.33 52 Week Low US$6.10 Beta 0.97 1 Month Change 7.68% 3 Month Change 11.11% 1 Year Change -53.02% 3 Year Change -89.06% 5 Year Change -87.87% Change since IPO -67.97%
Recent News & Updates
Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution Nov 26
Teladoc Health, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2024 Nov 02
Third quarter 2024 earnings released: US$0.19 loss per share (vs US$0.35 loss in 3Q 2023) Nov 01
Teladoc Health, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Oct 17
Teladoc Health, Inc. Appoints Joseph Catapano as its Senior Vice President and Chief Accounting Officer Sep 11
Second quarter 2024 earnings released: US$4.92 loss per share (vs US$0.40 loss in 2Q 2023) Aug 02 See more updates
Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution Nov 26
Teladoc Health, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2024 Nov 02
Third quarter 2024 earnings released: US$0.19 loss per share (vs US$0.35 loss in 3Q 2023) Nov 01
Teladoc Health, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Oct 17
Teladoc Health, Inc. Appoints Joseph Catapano as its Senior Vice President and Chief Accounting Officer Sep 11
Second quarter 2024 earnings released: US$4.92 loss per share (vs US$0.40 loss in 2Q 2023) Aug 02
Teladoc Health, Inc. to Report Q2, 2024 Results on Jul 31, 2024 Jul 18
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell 1000 Dynamic Index Jul 03
Teladoc Health, Inc. Releases New Data from Two Studies Jun 24 Teladoc Health, Inc. Appoints Charles Divita, III as Director
Robbins Geller Rudman & Dowd LLP Announces Class Action Lawsuit against Teladoc Health, Inc May 18
Teladoc Health, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024 Apr 27
First quarter 2024 earnings released: US$0.49 loss per share (vs US$0.42 loss in 1Q 2023) Apr 26 Teladoc Health, Inc. to Report Q1, 2024 Results on Apr 25, 2024
Teladoc Health, Inc., Annual General Meeting, May 23, 2024 Apr 10 Teladoc Health, Inc. Announces Chief Executive Officer Changes Apr 05
Full year 2023 earnings released: US$1.34 loss per share (vs US$84.60 loss in FY 2022) Feb 21
No longer forecast to breakeven Feb 21
No longer forecast to breakeven Feb 21
Teladoc Health, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024 Feb 21
Teladoc Health, Inc. to Report Q4, 2023 Results on Feb 20, 2024 Feb 02
Forecast to breakeven in 2026 Dec 31
Insufficient new directors Dec 01
Teladoc Health, Inc. Announces Resignation of Claus T. Jensen, PhD as Chief Innovation Officer Effective December 1, 2023 Nov 17
Teladoc Health, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2023 Oct 25
Third quarter 2023 earnings released: US$0.35 loss per share (vs US$0.45 loss in 3Q 2022) Oct 25
Teladoc Health, Inc. to Report Q3, 2023 Results on Oct 24, 2023 Oct 12
Teladoc Health, Inc. Appoints Eric Evans to Board of Directors Sep 21
New minor risk - Shareholder dilution Aug 03
Teladoc Health, Inc. Provides Earnings Guidance for the Third Quarter of 2023 and Year Ending December 31, 2023 Jul 26
Second quarter 2023 earnings released: US$0.40 loss per share (vs US$19.22 loss in 2Q 2022) Jul 26
Teladoc Health, Inc. to Report Q2, 2023 Results on Jul 25, 2023 Jul 12
Teladoc Health, Inc. to Report Q2, 2023 Results on Jul 25, 2023 Jul 11
New minor risk - Share price stability Jul 07
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell 1000 Growth Index Jun 25
First quarter 2023 earnings released: US$0.42 loss per share (vs US$41.58 loss in 1Q 2022) Apr 28
Now 24% undervalued Apr 19
CEO & Director recently sold €539k worth of stock Mar 09
Full year 2022 earnings released: US$84.60 loss per share (vs US$2.73 loss in FY 2021) Feb 24
Teladoc Health, Inc. to Report Q4, 2022 Results on Feb 22, 2023 Feb 02
Teladoc Health Launches Fully Integrated Whole-Person Care Experience with New App Jan 06
Chief People Officer recently sold €63k worth of stock Dec 01
Third quarter 2022 earnings released: US$0.45 loss per share (vs US$0.53 loss in 3Q 2021) Oct 27
Teladoc Health, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022 Oct 27
Teladoc Health Inc. Appoints Laizer Kornwasser as President, Enterprise Growth & Global Markets Oct 25
Teladoc Health, Inc. to Report Q3, 2022 Results on Oct 26, 2022 Oct 12
Teladoc Health, Inc.(NYSE:TDOC) dropped from FTSE All-World Index (USD) Sep 19
Chief People Officer recently sold €141k worth of stock Aug 30
Second quarter 2022 earnings released: US$19.22 loss per share (vs US$0.86 loss in 2Q 2021) Jul 28 Teladoc Health, Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2022
Teladoc Health, Inc. Appoints Mike Waters as Chief Operating Officer Jul 26
Teladoc Health’S Integrated Chronic Care Solutions Deliver Improved Health Outcomes Jul 16
Teladoc Health, Inc. to Report Q2, 2022 Results on Jul 27, 2022 Jul 13
Jakubowitz Law Reminds Teladoc Shareholders of a Lead Plaintiff Deadline of August 5, 2022 Jul 09
Gainey McKenna & Egleston Files Class Action Lawsuit Against Teladoc Health, Inc Jun 08
Chief People Officer recently sold €86k worth of stock Jun 01
Teladoc Health, Inc. Reports Goodwill Impairment for the First Quarter Ended March 31, 2022 Apr 29
First quarter 2022 earnings released: US$41.58 loss per share (vs US$1.31 loss in 1Q 2021) Apr 28
Teladoc Health, Inc. Appoints Vidya Raman-Tangella as Chief Medical Officer Apr 26
Teladoc Health, Inc., Annual General Meeting, May 26, 2022 Apr 13
Teladoc Health, Inc. to Report Q1, 2022 Results on Apr 27, 2022 Apr 07
Chief Human Resources Officer recently sold €182k worth of stock Mar 09
Forecast to breakeven in 2024 Feb 24
Teladoc Health, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2022 Feb 24
Teladoc Health, Inc. Launches “Chronic Care Complete” as First Unified Chronic Condition Management Experience Feb 18
Teladoc Health, Inc. to Report Q4, 2021 Results on Feb 22, 2022 Feb 02
Teladoc Health, Inc. Provides Revenue Guidance for the Year Ending December 31, 2021 Jan 12
Chief Human Resources Officer recently sold €376k worth of stock Dec 01
Third quarter 2021 earnings released: US$0.53 loss per share (vs US$0.43 loss in 3Q 2020) Oct 28
Chief Operating Officer David Sides has left the company Oct 01
Chief Operating Officer David Sides has left the company Sep 24
Chief Human Resources Officer recently sold €493k worth of stock Aug 29
No longer forecast to breakeven Jul 29
Second quarter 2021 earnings released: US$0.86 loss per share (vs US$0.34 loss in 2Q 2020) Jul 28 Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell Midcap Growth Index
Chief Human Resources Officer recently sold €475k worth of stock May 30
Director has left the company May 24
Independent Director has left the company May 24
Teladoc Health Launches “myStrength Complete” As First Unified Mental Health Care Experience May 12 Teladoc Health, Inc. Raises Earnings Guidance for Full Year 2021
First quarter 2021 earnings released: US$1.31 loss per share (vs US$0.40 loss in 1Q 2020) Apr 30
New 90-day low: €151 Mar 10
Chief Human Resources Officer recently sold €717k worth of stock Mar 02
Full year 2020 earnings released: US$5.36 loss per share (vs US$1.38 loss in FY 2019) Feb 26
Revenue misses expectations Feb 26
Teladoc Health, Inc. to Report Q4, 2020 Results on Feb 24, 2021 Feb 11
New 90-day high: €243 Feb 10
Richard J. Napolitano Joins Teladoc Health, Inc. as Senior Vice President, Chief Accounting Officer and Controller Jan 31
Moda Health and Teladoc Health Partner to Help Oregonians and Alaskans with Diabetes Live Healthier, Happier Lives with New Technology Jan 29
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell 2000 Dynamic Index Jan 28
New 90-day high: €205 Jan 21 Shareholder Returns 4LL DE Healthcare Services DE Market 7D -9.8% 0.2% -2.6% 1Y -53.0% -20.6% 7.1%
See full shareholder returns
Return vs Market: 4LL underperformed the German Market which returned 7.1% over the past year.
Price Volatility Is 4LL's price volatile compared to industry and market? 4LL volatility 4LL Average Weekly Movement 9.6% Healthcare Services Industry Average Movement 6.1% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.6% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: 4LL's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 4LL's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Show more Teladoc Health, Inc. Fundamentals Summary How do Teladoc Health's earnings and revenue compare to its market cap? 4LL fundamental statistics Market cap €1.48b Earnings (TTM ) -€940.89m Revenue (TTM ) €2.48b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 4LL income statement (TTM ) Revenue US$2.59b Cost of Revenue US$755.77m Gross Profit US$1.83b Other Expenses US$2.82b Earnings -US$981.73m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -5.70 Gross Margin 70.82% Net Profit Margin -37.91% Debt/Equity Ratio 102.2%
How did 4LL perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/20 23:49 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Teladoc Health, Inc. is covered by 44 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution null null Argus Research Company Vikram Kesavabhotla Baird Matthew Gillmor Baird
Show 41 more analysts 
